| | CambridgeIP is a provider of business and technology intelligence and innovation strategy services to companies around the world. CambridgeIP's work has been covered in leading publications, including the Harvard Business Review, Wall Street Journal and Bloomberg. CambridgeIP runs Boliven.com - a leading online information portal making available over 100 million scientific documents, and training to private and public organisations in high-technology sectors. |
|
Contact Us
Office Address:
8A Kings Parade
Cambridge
CB2 1SJ
United Kingdom
e: media@cambridgeip.com
t: +44 1223 778846 (UK)
t: +1 617 500 8572 (USA)
f: +44 20 3357 3105
 Read our Blog Follow us on Twitter
 Connect on LinkedIn
 View us on YouTube
 |
|
|
|
Greetings!
Happy 2012! Here at CambridgeIP we wanted to send our best wishes to you for the coming year. We would like to share with you some recent news about CambridgeIP's products and activities.
Don't forget you can start searching over 100 million scientific documents today with your free trial on Boliven.com. Give it a try and let us know what you think.
If you have any comments or questions about any of our recent news and activities visit us at cambridgeip.com or feel free to contact us. We look forward to hearing from you!
The CambridgeIP Team
|
|
Exploiting carbon flatland
Seven years after graphene was first isolated, our analysis of the densely populated patent landscape around the two-dimensional material reveals striking differences between universities' patenting activities and illustrates the challenges of a fast-moving technology space.
In an article for Nature Materials Quentin Tannock from CambridgeIP highlights University-Industry collaboration activity and key findings from CambridgeIP research into the graphene patent landscape.
"One of the striking features of the graphene patent landscape is what is not present. The University of Manchester has applied for significantly fewer patents than its peers... The chance of an academic inventor receiving an investment to roll out a commercial graphene application is less than in the past. Finding corporate strategic partners is now even more important." - Tannock, Q. Exploiting carbon flatland, Nature Materials Vol 11, January 2012, pgs 2-5
Read the article | Learn more
|
|
CambridgeIP Report on Graphene
The research underpinning the Nature Materials article and much more can be found in CambridgeIP's recently published report 'Patenting Flatland: Graphene'. This report investigates the particular role and impact that universities and academics institutions have to play in the development of graphene technology.
As the first 2D crystal discovered and with unusual electronic, optical and mechanical properties, graphene is of interest across industry fields as diverse Aerospace, Biotech, Energy, Industrial Chemicals and Semiconductors. The UK's Chancellor of the Exchequer, George Osborne, has recently announced a £50 million grant to support UK-based graphene research and "fund a national research programme that will take this Nobel Prize-winning discovery from the British laboratory to the British factory floor" "Despite playing host to Nobel Prize-winning graphene researchers, UK academic institutions currently hold far fewer graphene patents than their peers in China, South Korea and the USA. The graphene patent flatland is expanding rapidly - for example, evidence is now emerging of an increased rate of patent applications by the University of Manchester." Quentin Tannock (Chairman, CambridgeIP)
Request the Report | Learn More
|
CambridgeIP report on Desalination
The CambridgeIP report 'Desalination Technologies and the use of alternative energies for Desalination' was commissioned by the World Intellectual Property Office (WIPO) and the International Renewable Energy Agency (IRENA).
The report focuses on desalination technologies, and in particular on desalination technology integration with five different renewable energy sources.
The report reviews key desalination technologies that are currently commercially deployed (with some indicative energy spend figures), and technologies currently in the R D phase. We also review the 'direct' and 'indirect' modes of integration with renewable energy sources. The patent landscaping is focused on the 'direct' modes of integration, but we provide some case study examples of 'indirect' integration, which may be a major growth area in the future.
For more information please see our Energy & Clean Technology page or contact us at info@cambridgeip.com.
Learn More
|
|
CambridgeIP Report on Solar Technology
A recent CambridgeIP company technology report titled 'First Solar, Inc. (Nasdaq: FSLR) - A Focus on the Technology Fundamentals' finds that First Solar has had a record year in patent filing activity, but analysis suggests new entrants in CdTe Solar PV from China.
CambridgeIP report finds First Solar's patenting activities have largely outstripped that of its key competitors in Europe and China. CambridgeIP's analysis reveals a patent portfolio of 337 patents and patent applications, with more than 100 filed in 2010. The analysis confirms First Solar's technology leadership in the CdTe-based Solar PV space, and identifies key collaborations and licensing partners. However, the analysis revealed a weak patent coverage in Asia. "First Solar is one of the few non-Chinese companies that combines scale and a strong patenting and technology base. This places it well to compete in the evolving Solar PV industry landscape. Key to its continued ability to compete with the large manufacturing capacity accumulated by Chinese Solar PV companies is an ability to scale-up its latest technology rapidly, and protect its unique technology. Access to a strong IP base will prove key to protecting technology-based differentiation for US, EU and Asian PV technology companies alike, as it can underpin the rapid scale-up of next generation technologies and protect key markets from copy-cat entry" said Ilian Iliev (CEO, CambridgeIP).
See the Report on Boliven.com | Learn More
|
|
Boliven enhanced features and updates
We are delighted to introduce new upgraded features included API access to Boliven data and Clinical trial data refreshed. Don't forget that you can start your free BolivenPRO trial on Boliven.com here. Give it a try and let us know what you think!
API access to Boliven data:
BolivenPRO subscribers can now obtain API access to Boliven data and Lists, which eases integration with your internal systems and processes. The Boliven API is an extremely powerful interface to the boliven data repository, allowing programatic interfaces to search and query 100 million+ documents. Clinical Trials on Boliven.com: Boliven.com now has data on over 112,000 clinical trials. Simply choose Clinical Trials from the search menu and instantly discover data on thousands of clinical trials, including information on trial status, medical conditions, study type, phase, key dates, officials and Sponsors involved. Use this information to: - discover what companies are sponsoring what trials.
- expand your search to look at their corresponding patents and critical data.
Click here to start your clinical trial search.
If you have any questions about your API needs, Boliven shopping basket or Boliven data coverage, please don't hesitate to
contact us.
Learn more
|
|
Technology Strategy Board awards grants to CambridgeIP
UK government grants will help CambridgeIP secure a step-change in the way science literature and intellectual property (IP) intelligence is developed and accessed.
The UK government's Technology Strategy Board (TSB) has awarded grants to CambridgeIP to build on the company's exceptional work in meeting the strategic information needs of R&D intensive organisations around the world. CambridgeIP has already launched 'Proof of Market' and 'Proof of Concept' projects on the back of the TSB grants. The interactive projects are open to participation by business users in all industries and of all sizes - CambridgeIP is already working with end users including Fortune 500 companies and SMEs under the projects.
CambridgeIP's CEO Ilian Iliev explained:
"We want to bring patent landscaping and science literature landscaping best practice into the modern era. Our next generation of tools will lead to a step-change in the way IP intelligence is developed and accessed by major organisations, and facilitate Open Innovation initiatives in Corporations and SMEs alike."
Learn More
|
|
More CambridgeIP Reports...
CambridgeIP research continues to expand the topics covered by its reports as demand increases from our clients.
CambridgeIP reports are written by our in-house and industry experts. The reports are based on patent datasets carefully compiled and cleaned by our experts. The reports are designed for technology sector executives including inventors, R&D and IP managers, investors and patent research professionals. You can also purchase the underlying patent datasets which you can use for your in-house research needs. 'Recent trends in nanotechnology patenting (2005-2011)'. An analysis of patenting trends in nanotechnology in the last 5 years. The report comprises analytics including top ranking patenting organisations, top ranking industry application (IPC) codes and patent application trends over time.  'Blood glucose monitors and wireless communication'. It comprises an expert derived and up-to-date patent dataset covering the wireless glucometer space, plus analytics including top ranking patenting organisations, top ranking IPC codes and patent application trends over time. 'Pandemic influenza H1N1 (swine flu) and H5N1 (bird flu) patenting trends'. This FREE Boliven Landscape presents an analysis of patenting trends in pandemic influenza preparedness relevant to the H5N1 and H1N1 viruses over the past several years. Contact us to let us know what topics you would like to see covered next!
Learn More
|
|
|
|
|
